CAMBRIDGE, Mass. — ConcertAI said two NCI-designated cancer centers have joined its CancerLinQ network, expanding the platform’s reach and ability to generate real-world evidence across oncology care settings.
The Cambridge-based real-world health care intelligence company said University of Rochester Medicine Wilmot Cancer Institute and UCHealth/University of Colorado Anschutz Cancer Center are now using CancerLinQ to support quality improvement, research and more personalized cancer care.
ConcertAI said the additions will help turn routine clinical practice into actionable intelligence that can inform care delivery and research. The company said cancer centers are under increasing pressure to improve outcomes, reduce administrative burden and deliver more personalized treatment, making timely clinical data more important.
CancerLinQ Suite uses artificial intelligence to curate longitudinal oncology data from more than 900 sites of care across all 50 states each week. ConcertAI said the platform is designed to move beyond legacy systems that rely mainly on structured data, using AI-powered tools to provide more complete and timely insights for oncologists.
The platform standardizes and harmonizes data to connect clinical findings with other factors that shape patient care, including activity level.
“As oncology care becomes increasingly complex, organizations need stronger ways to translate data into continuous learning and consistent improvements in practice,” said Shaalan Beg, M.D., chief medical officer, oncology, ConcertAI. “By expanding the CancerLinQ network with leading institutions at the forefront of data-driven oncology, such as Wilmot Cancer Institute and UCHealth/University of Colorado Anschutz Cancer Center, we are helping strengthen clinical performance and accelerate data-driven quality improvement across cancer care.”
ConcertAI said CancerLinQ helps oncology teams use data from patient encounters for quality measurement, national benchmarking and faster clinical trial enrollment. The company said the participating cancer centers reflect a newer generation of oncology programs that view data and technology as central to improving care delivery.
Wilmot Cancer Institute, an NCI-designated cancer center, is using CancerLinQ to generate real-time quality metrics for clinical teams. The institute is known for its multidisciplinary approach and clinical research work.
“Wilmot Cancer Institute is proud to have earned many certifications, including the ASCO Quality Oncology Practice Initiative (QOPI) certification, which requires gathering and analyzing data. CancerLinQ has provided an opportunity to automate this data collection process in a HIPAA-compliant, de-identified manner,” said Arpan Patel, M.D., MBA, chief quality officer at Wilmot Cancer Institute. “This enables our providers to review real-time data related to their patients and compare their own care metrics with providers at our institution and other cancer centers across the country. CancerLinQ can help us identify opportunities to improve patient care and workflows faster, rather than waiting weeks or months for the data that can help drive improvements.”
The University of Colorado Anschutz Cancer Center, Colorado’s only NCI-designated comprehensive cancer center, operates in clinical partnership with UCHealth and is one of the most research-active oncology programs in the Rocky Mountain region. The center joined CancerLinQ to support its quality program, including QOPI certification, and to access CancerLinQ Discovery, a real-world oncology research dataset spanning more than 11 million patients.
“CancerLinQ gives us the ability to see our performance across providers and disease types, in a way that wasn’t possible when we were doing manual chart reviews with small patient subsets. This collaboration allows our teams to learn from real-world data at scale. That combination of actionable quality intelligence and research insight is critical to continuously improving how we deliver cancer care,” said Wells Messersmith, M.D., associate director for clinical services at the University of Colorado Anschutz Cancer Center, head of the Division of Medical Oncology at the CU Department of Medicine and chief medical officer of oncology services at UCHealth.
